Company: REVB
Filing Date: 2025-09-16
Form Type: S-3
Source: 0001193125-25-205145
Chunk: 21

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-09-16
Form: S-3
Chunk 21
---
ant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.

<div align='center'>17</div>

SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of San Diego, California, on September 16, 2025.

| Revelation Biosciences, Inc. |                         |
| By:                          | /s/ James Rolke         |
|                              | Chief Executive Officer |

POW ER OF ATTORNEY Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated, each of whom also constitutes and appoints Chester S. Zygmont, III, and each of them singly, his true and lawful attorney-in-fact and agent, for him or her, with full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign any and all amendments to this Registration Statement, and to file the same and all exhibits thereto and any other documents in connection therewith with the Securities and Exchange Commission, granting unto each attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that each attorney-in-fact and agent or his or her substitute or substitutes may lawfully do or cause to be done by virtue hereof.

| By: |     | /s/ James Rolke                                          |
|     |     | Chief Executive Officer, Chairman and Director           |
| By: |     | /s/ Chester S. Zygmont, III                              |
|     |     | Chief Financial Officer and Principal Accounting Officer |
| By: |     | Jennifer Carver*                                         |
|     |     | Director                                                 |
| By: |     | Jess Roper*                                              |
|     |     | Director                                                 |
| By: |     | L